vs
Side-by-side financial comparison of NETSOL TECHNOLOGIES INC (NTWK) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
NETSOL TECHNOLOGIES INC is the larger business by last-quarter revenue ($18.8M vs $12.6M, roughly 1.5× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 1.3%, a 249.4% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 21.1%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 10.3%).
NetSol Technologies Inc. is an American software company which makes automobile leasing software. It is based in Encino, California.
NTWK vs SPRO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.8M | $12.6M |
| Net Profit | $246.8K | $31.5M |
| Gross Margin | 48.0% | — |
| Operating Margin | 6.9% | — |
| Net Margin | 1.3% | 250.7% |
| Revenue YoY | 21.1% | 24080.8% |
| Net Profit YoY | 121.5% | 250.9% |
| EPS (diluted) | $0.02 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.8M | $12.6M | ||
| Q3 25 | $15.0M | $0 | ||
| Q2 25 | $18.4M | $0 | ||
| Q1 25 | $17.5M | $12.0K | ||
| Q4 24 | $15.5M | $52.0K | ||
| Q3 24 | $14.6M | $65.0K | ||
| Q2 24 | $16.4M | $114.0K | ||
| Q1 24 | $15.5M | $140.0K |
| Q4 25 | $246.8K | $31.5M | ||
| Q3 25 | $-2.4M | $-7.4M | ||
| Q2 25 | $2.6M | $-1.7M | ||
| Q1 25 | $1.4M | $-13.9M | ||
| Q4 24 | $-1.1M | — | ||
| Q3 24 | $70.8K | $-17.1M | ||
| Q2 24 | $-82.9K | $-17.9M | ||
| Q1 24 | $327.5K | $-12.7M |
| Q4 25 | 48.0% | — | ||
| Q3 25 | 39.4% | — | ||
| Q2 25 | 56.2% | — | ||
| Q1 25 | 49.8% | — | ||
| Q4 24 | 44.5% | — | ||
| Q3 24 | 45.0% | — | ||
| Q2 24 | 51.5% | — | ||
| Q1 24 | 48.3% | — |
| Q4 25 | 6.9% | — | ||
| Q3 25 | -12.2% | — | ||
| Q2 25 | 17.4% | — | ||
| Q1 25 | 8.9% | -122758.3% | ||
| Q4 24 | -3.1% | — | ||
| Q3 24 | -5.2% | -28604.6% | ||
| Q2 24 | 4.9% | -16720.2% | ||
| Q1 24 | 8.5% | -9987.1% |
| Q4 25 | 1.3% | 250.7% | ||
| Q3 25 | -15.7% | — | ||
| Q2 25 | 14.0% | — | ||
| Q1 25 | 8.1% | -115550.0% | ||
| Q4 24 | -7.4% | — | ||
| Q3 24 | 0.5% | -26380.0% | ||
| Q2 24 | -0.5% | -15668.4% | ||
| Q1 24 | 2.1% | -9049.3% |
| Q4 25 | $0.02 | $0.56 | ||
| Q3 25 | $-0.20 | $-0.13 | ||
| Q2 25 | $0.22 | $-0.03 | ||
| Q1 25 | $0.12 | $-0.25 | ||
| Q4 24 | $-0.10 | — | ||
| Q3 24 | $0.01 | $-0.32 | ||
| Q2 24 | $-0.01 | $-0.33 | ||
| Q1 24 | $0.03 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.1M | $40.3M |
| Total DebtLower is stronger | $337.0K | — |
| Stockholders' EquityBook value | $35.9M | $59.0M |
| Total Assets | $62.7M | $68.9M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.1M | $40.3M | ||
| Q3 25 | $22.7M | $48.6M | ||
| Q2 25 | $17.4M | $31.2M | ||
| Q1 25 | $18.8M | $48.9M | ||
| Q4 24 | $21.3M | $52.9M | ||
| Q3 24 | $24.5M | $76.3M | ||
| Q2 24 | $19.1M | $63.5M | ||
| Q1 24 | $12.3M | $82.3M |
| Q4 25 | $337.0K | — | ||
| Q3 25 | $218.2K | — | ||
| Q2 25 | $134.6K | — | ||
| Q1 25 | $86.8K | — | ||
| Q4 24 | $87.0K | — | ||
| Q3 24 | $92.6K | — | ||
| Q2 24 | $95.8K | — | ||
| Q1 24 | $130.4K | — |
| Q4 25 | $35.9M | $59.0M | ||
| Q3 25 | $35.8M | $26.5M | ||
| Q2 25 | $37.8M | $32.8M | ||
| Q1 25 | $35.5M | $33.8M | ||
| Q4 24 | $33.9M | $46.1M | ||
| Q3 24 | $34.7M | $65.5M | ||
| Q2 24 | $34.8M | $80.5M | ||
| Q1 24 | $35.3M | $96.2M |
| Q4 25 | $62.7M | $68.9M | ||
| Q3 25 | $62.6M | $54.2M | ||
| Q2 25 | $62.4M | $62.1M | ||
| Q1 25 | $58.1M | $77.7M | ||
| Q4 24 | $59.1M | $110.5M | ||
| Q3 24 | $62.8M | $135.2M | ||
| Q2 24 | $64.2M | $149.9M | ||
| Q1 24 | $63.3M | $167.7M |
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.7M | $-8.4M |
| Free Cash FlowOCF − Capex | $-5.1M | — |
| FCF MarginFCF / Revenue | -27.2% | — |
| Capex IntensityCapex / Revenue | 2.0% | — |
| Cash ConversionOCF / Net Profit | -19.24× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $-1.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.7M | $-8.4M | ||
| Q3 25 | $5.3M | $17.4M | ||
| Q2 25 | $441.0K | $-17.7M | ||
| Q1 25 | $-363.4K | $-4.0M | ||
| Q4 24 | $-5.1M | $-23.4M | ||
| Q3 24 | $5.5M | $12.8M | ||
| Q2 24 | $6.5M | $-18.7M | ||
| Q1 24 | $-4.2M | $5.9M |
| Q4 25 | $-5.1M | — | ||
| Q3 25 | $4.8M | — | ||
| Q2 25 | $-44.1K | — | ||
| Q1 25 | $-693.0K | — | ||
| Q4 24 | $-5.6M | — | ||
| Q3 24 | $5.4M | — | ||
| Q2 24 | $6.1M | — | ||
| Q1 24 | $-4.6M | — |
| Q4 25 | -27.2% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | -0.2% | — | ||
| Q1 25 | -4.0% | — | ||
| Q4 24 | -36.1% | — | ||
| Q3 24 | 37.1% | — | ||
| Q2 24 | 37.0% | — | ||
| Q1 24 | -29.6% | — |
| Q4 25 | 2.0% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 2.4% | — |
| Q4 25 | -19.24× | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | -0.26× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 77.94× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -12.84× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NTWK
| Core Revenue | $18.0M | 96% |
| Other | $816.8K | 4% |
SPRO
Segment breakdown not available.
